Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZSAN

Zosano Pharma (ZSAN) Stock Price, News & Analysis

Zosano Pharma logo

About Zosano Pharma Stock (NASDAQ:ZSAN)

Advanced Chart

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.52
$112.00
52-Week Range
$0.46
$37.45
Volume
5,685 shs
Average Volume
425,375 shs
Market Capitalization
$980.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZSAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zosano Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZSAN Stock News Headlines

Aktuelle Empfehlungen zur ZOSANO
Trump’s Plan May Undo 1933’s Biggest Financial Injustice
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.tc pixel
HOOK HOOKIPA Pharma Inc.
East Bay Business News
Astellas Pharma
Zosano Pharma Corporation (ZSANQ)
See More Headlines

ZSAN Stock Analysis - Frequently Asked Questions

Zosano Pharma Co. (NASDAQ:ZSAN) posted its quarterly earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) EPS for the quarter, missing the consensus estimate of ($1.75) by $0.01. Zosano Pharma had a negative trailing twelve-month return on equity of 177.06% and a negative net margin of 8,375.11%.

Zosano Pharma's stock reverse split on Tuesday, April 12th 2022.The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Zosano Pharma (ZSAN) raised $47 million in an initial public offering (IPO) on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zosano Pharma investors own include Tonix Pharmaceuticals (TNXP), NIO (NIO), Adamis Pharmaceuticals (ADMP), Bionano Genomics (BNGO), NightHawk Biosciences (NHWK), Sorrento Therapeutics (SRNE) and Aeterna Zentaris (AEZS).

Company Calendar

Last Earnings
5/13/2022
Today
9/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZSAN
CIK
1587221
Fax
N/A
Employees
40
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
($14.5034)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.92 million
Net Margins
-8,375.11%
Pretax Margin
-8,375.11%
Return on Equity
-177.06%
Return on Assets
-119.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.61
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$790 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.74 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
4,902,000
Free Float
4,784,000
Market Cap
$980.40
Optionable
Not Optionable
Beta
3.30

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ZSAN) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners